FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Comparision between IREDA IPO and Mukka Proteins IPO.
IREDA IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Mukka Proteins IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.
IREDA IPO | Mukka Proteins IPO | |
---|---|---|
Logo | ||
Issue Category | Mainline | Mainline |
Issue Type | IPO | IPO |
Process Type | Book Built Issue | Book Built Issue |
Listing At | BSE, NSE | BSE, NSE |
Lead Managers | Idbi Capital Market Services Limited Bob Capital Markets Limited SBI Capital Markets Limited |
Fedex Securities Pvt Ltd |
Registrar | Link Intime India Private Ltd | Cameo Corporate Services Limited |
Market Maker | ||
DRHP | DRHP | DRHP |
RHP | RHP | RHP |
Anchor Investor | Anchor Investor | Anchor Investor |
IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of IREDA IPO is up to ₹2,150.21 Cr whereas the issue size of the Mukka Proteins IPO is up to ₹224.00 Cr. The final issue price of IREDA IPO is ₹32.00 per share and of Mukka Proteins IPO is ₹28.00 per share.
IREDA IPO | Mukka Proteins IPO | |
---|---|---|
Face Value | ₹10 per share | ₹1 per share |
Issue Price (Lower) | ₹30.00 per share | ₹26.00 per share |
Issue Price (Upper) | ₹32.00 per share | ₹28.00 per share |
Issue Price (Final) | ₹32.00 per share | ₹28.00 per share |
Discount (Retail) | ||
Discount (Employee) | ||
Market Lot Size | 460 shares | 535 shares |
Fresh Issue Size | 40,31,64,706 shares | 8,00,00,000 shares |
Fresh Issue Size (Amount) | up to ₹1,290.13 Cr | up to ₹224.00 Cr |
OFS Issue Size | 26,87,76,471 shares | |
OFS Issue Size (Amount) | up to ₹860.08 Cr | |
Issue Size Total | 67,19,41,177 shares | 8,00,00,000 shares |
Issue Size Total (Amount) | up to ₹2,150.21 Cr | up to ₹224.00 Cr |
IREDA IPO opens on Nov 21, 2023, while Mukka Proteins IPO opens on Feb 29, 2024. The closing date of IREDA IPO and Mukka Proteins IPO is Nov 23, 2023, and Mar 04, 2024, respectively.
IREDA IPO | Mukka Proteins IPO | |
---|---|---|
Anchor Bid Date | Nov 20, 2023 | Feb 28, 2024 |
Issue Open | Nov 21, 2023 | Feb 29, 2024 |
Issue Close | Nov 23, 2023 | Mar 04, 2024 |
Basis Of Allotment (Tentative) | Nov 24, 2023 | Mar 05, 2024 |
Initiation of Refunds (Tentative) | Nov 25, 2023 | Mar 06, 2024 |
Credit of Share (Tentative) | Nov 28, 2023 | Mar 06, 2024 |
Listing date (Tentative) | Nov 29, 2023 | Mar 07, 2024 |
Anchor Lockin End date 1 | Dec 24, 2023 | Apr 04, 2024 |
Anchor Lockin End date 2 | Feb 22, 2024 | Jun 03, 2024 |
IREDA IPO P/E ratio is 8.47, as compared to Mukka Proteins IPO P/E ratio of 12.96.
IREDA IPO | Mukka Proteins IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial | Indian Renewable Energy Development Agency Limited Financial Information (Restated Standalone)Indian Renewable Energy Development Agency Limited's revenue increased by 21.18% and profit after tax (PAT) rose by 36.48% between the financial year ending with March 31, 2023 and March 31, 2022.
|
Mukka Proteins Limited Financial Information (Restated Consolidated)Mukka Proteins Limited's revenue increased by 52.52% and profit after tax (PAT) rose by 84.07% between the financial year ending with March 31, 2023 and March 31, 2022.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Pre-Issue) | 100% | 100% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Post-Issue) | 75% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
P/E Ratio | 8.47 | 12.96 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Market Cap | ₹8600.85 Cr. | ₹840.00 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROE | 15.44%% | 36.71%% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROCE | 17.62%% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt/Equity | 6.77 | 1.64 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
EPS | ₹3.78 | ₹2.16 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RoNW | 15.44%% | 34.19%% |
In the IREDA IPO retail investors (RII) are offered 23,45,23,015 shares while in Mukka Proteins IPO retail investors are offered 23,45,23,015 shares. Qualified institutional buyers (QIB) are offered 13,40,13,152 shares in IREDA IPO and 1,60,00,435 shares in Mukka Proteins IPO.
IREDA IPO | Mukka Proteins IPO | |
---|---|---|
Anchor Investor Reserveration | 20,10,19,726 shares | 2,39,99,565 shares |
Market Maker Reserveration | ||
QIB | 13,40,13,152 shares | 1,60,00,435 shares |
NII | 10,05,09,864 shares | 1,20,00,000 shares |
RII | 23,45,23,015 shares | 2,80,00,000 shares |
Employee | 18,75,420 shares | 0 shares |
Others | ||
Total | 47,09,21,451 shares | 5,60,00,435 shares |
IREDA IPO subscribed 38.80x in total, whereas Mukka Proteins IPO subscribed 136.99x.
IREDA IPO | Mukka Proteins IPO | |
---|---|---|
QIB (times) | 104.57x | 189.28x |
NII (times) | 24.16x | 250.39x |
Big NII (times) | 26.99x | 254.15x |
Small NII (times) | 18.50x | 242.86x |
RII (times) | 7.73x | 58.52x |
Employee (times) | 9.80x | |
Other (times) | ||
Total (times) | 38.80x | 136.99x |
Add a public comment...
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|